Clinical trials in Brussels – page 20

261 clinical trials in Brussels, Belgium across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Brussels at a glance

261

clinical trials

Research sites6

Quick filters

261 trials in Brussels

Open in trial search

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Tuvusertib and Cemiplimab for Patients with Non-Squamous Non-Small Cell Lung Cancer After Previous Treatments

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Cemiplimab
Sponsor:Merck Healthcare KGaA

Contact Research Centre

Breast cancer

Not recruiting

InvestigationalNo placebo

Study of Trastuzumab Deruxtecan for Patients with Unresectable or Metastatic HER2-low or HER2 IHC0 Breast Cancer

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Trastuzumab Deruxtecan
Sponsor:Daiichi Sankyo Inc.

Contact Research Centre

Pleural mesothelioma

Not recruiting

Registered drugNo placebo

Study of Volrustomig with Carboplatin and Pemetrexed for Patients with Unresectable Pleural Mesothelioma

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:AstraZeneca AB

Contact Research Centre

Follicular lymphoma+1

Not recruiting

Registered drug

Study of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Lenalidomide
Sponsor:Incyte Corp.

Contact Research Centre

HIV infection

Not recruiting

Registered drugNo placebo

Study Comparing Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Treatment in Adults New to Antiretroviral Therapy

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Bictegravir
Sponsor:Viiv Healthcare UK Limited

Contact Research Centre

Lung disorder

Not recruiting

Registered drug

Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Baricitinib
Sponsor:Oslo University Hospital HF

Contact Research Centre

Lung disorder

Not recruiting

Investigational

Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Bemcentinib
Sponsor:Oslo University Hospital HF

Contact Research Centre

Monkeypox

Not recruiting

Registered drugNo placebo

Study on Monkeypox Virus Disease: Effects of Tecovirimat in Patients with and without Antiviral Treatment

Registered drugNo placebo

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Tecovirimat
Sponsor:University Of Oxford

Contact Research Centre

Hepatitis D

Not recruiting

Registered drugNo placebo

Study on Bulevirtide Treatment for Patients with Chronic Hepatitis D

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Bulevirtide
Sponsor:Gilead Sciences Inc.

Contact Research Centre

Urea cycle disorder+3

Not recruiting

InvestigationalNo placebo

Long-Term Safety Study of HepaStem for Patients with Urea Cycle Disorders, Crigler-Najjar Syndrome, and Fibroinflammatory Liver Diseases

InvestigationalNo placebo

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Hhalpc
Sponsor:Cellaïon SA

Contact Research Centre

Study on the Safety and Immune Response of GSK's Herpes Zoster Vaccine in Immunocompromised Children Aged 1-17 with Kidney Transplants

Not recruiting

InvestigationalNo placebo

Study on the Safety and Immune Response of GSK's Herpes Zoster Vaccine in Immunocompromised Children Aged 1-17 with Kidney Transplants

InvestigationalNo placebo

Belgium

Participants:0–17 years
Substances:Gskvx000000014593
Sponsor:GlaxoSmithKline Biologicals

Contact Research Centre

Colon cancer stage III+1

Not recruiting

Registered drug

Study on Aspirin for Preventing Recurrence and Improving Survival in Patients with Resected Colon Cancer

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Antwerp University Hospital

Contact Research Centre

Other cities in Belgium

The busiest research cities in the country

All 170 cities in Belgium

Clinical research in Brussels

What the registry says about research in the country

01 Infectious Diseases Research

Innovative clinical trials focusing on viral infections and preventive medicine, including studies on Herpes Simplex, Hepatitis D, and RSV prevention in infants.

HSV immunotherapy development
Chronic HDV treatment evaluation
Pertussis immunity in infants

Research includes novel therapeutic approaches and vaccine effectiveness studies.

02 Oncology Studies

Groundbreaking research in breast cancer treatment, particularly focusing on hormone receptor-positive cases and innovative therapeutic combinations.

Early-stage breast cancer treatments
Perioperative care optimization
Novel drug combinations

Studies aim to improve treatment outcomes and reduce surgical complications.

03 Respiratory Medicine

Advanced research in severe asthma management and lung cancer treatment, investigating new therapeutic approaches.

Non-small cell lung cancer therapy
Allergic and eosinophilic asthma treatment
Biological therapy comparison

Focus on personalized treatment approaches and targeted therapies.

Back to Belgium All countries